Melexis NV (LTS:0FA0)
€ 82.2 0.15 (0.18%) Market Cap: 3.34 Bil Enterprise Value: 3.48 Bil PE Ratio: 14.96 PB Ratio: 5.25 GF Score: 97/100

Q4 2020 Melexis NV Earnings Call Transcript

Feb 03, 2021 / 09:30AM GMT
Release Date Price: €93.78 (-3.27%)
Operator

Hello, and welcome to the Melexis full year 2020 results. My name is Judy, and I'll be the coordinator for today's event. Please note that the call is being recorded. (Operator Instructions)

I will now hand you over to your host, Francoise Chombar, CEO, to begin today's conference. Thank you.

Francoise Chombar
Melexis NV - CEO, MD & Executive Director

Thank you, operator. Dear audience, I sincerely hope that you and your close ones are all healthy and well. Thank you for joining the Melexis Fourth Quarter and Full Year 2020 Earnings Call.

Next, to new hopes for the vaccine, the new Year is bringing new opportunities. And together with Karen Van Griensven, our CFO, we'll be glad to talk to you about both the past and the future and answer any question you might have.

During the pandemic, the Melexis values were and are our best vaccine, and that shows in our 2020 results. Thanks to the proactive supply chain and inventory management that Melexis adopted and that allowed us to already sequentially grow 21% in sales for the third

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot